SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000903423-19-000302
Filing Date
2019-07-17
Accepted
2019-07-17 19:37:05
Documents
1
Period of Report
2019-07-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT fulcrum.html 3  
1 OWNERSHIP DOCUMENT fulcrum.xml 3 3323
  Complete submission text file 0000903423-19-000302.txt   4905
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Reporting) CIK: 0001131399 (see all company filings)

State of Incorp.: X0
Type: 3 | Act: 34 | File No.: 001-38978 | Film No.: 19960175
SIC: 2834 Pharmaceutical Preparations

Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Issuer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations